Contrasting Siemens Gamesa Renewable Energy (OTCMKTS:GCTAY) & Eisai (OTCMKTS:ESALY)

Valuation & Earnings

This table compares Siemens Gamesa Renewable Energy and Eisai”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Siemens Gamesa Renewable Energy	$12.19 billion	1.05	-$749.21 million	N/A	N/A
Eisai	$6.74 billion	2.62	$426.79 million	$0.87	70.70

Eisai has lower revenue, but higher earnings than Siemens Gamesa Renewable Energy.

Institutional and Insider Ownership

0.0% of Eisai shares are owned by institutional investors. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Profitability

This table compares Siemens Gamesa Renewable Energy and Eisai’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Siemens Gamesa Renewable Energy	N/A	N/A	N/A
Eisai	4.11%	3.86%	2.50%

Volatility and Risk

Siemens Gamesa Renewable Energy has a beta of 0.95, suggesting that its stock price is 5% less volatile than the S&P 500. Comparatively, Eisai has a beta of 0.31, suggesting that its stock price is 69% less volatile than the S&P 500.

Summary

Eisai beats Siemens Gamesa Renewable Energy on 6 of the 8 factors compared between the two stocks.

About Siemens Gamesa Renewable Energy

Siemens Gamesa supplies wind turbines and power solutions to customers. The company is a global leader in the renewable energy industry specifically in the development, installation, maintenance, and manufacturing of wind turbines. Siemens Gamesa’s vision is to be the global leader in the renewable energy industry driving the transition towards a sustainable world. Siemens Gamesa was founded in 1976 and is based in Zamudio, Spain.

About Eisai

Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the Pharmaceutical Products Business and Other Business segments. The Pharmaceutical Products Business segment handles prescription and generic drugs, diagnostics, and consumer healthcare business in Japan, which manages over-the-counter drugs. The Other Business segment deals with food additives and chemicals. The company was founded by Toyoji Naito in November 1936 and is headquartered in Tokyo, Japan.